428 related articles for article (PubMed ID: 24950924)
1. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
[TBL] [Abstract][Full Text] [Related]
2. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.
Manuthu EM; Joshi MD; Lule GN; Karari E
East Afr Med J; 2008 Jan; 85(1):10-7. PubMed ID: 18543521
[TBL] [Abstract][Full Text] [Related]
6. Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
Mengist HM; Taye B; Tsegaye A
PLoS One; 2015; 10(2):e0117715. PubMed ID: 25658626
[TBL] [Abstract][Full Text] [Related]
7. Malnutrition and lipid abnormalities in antiretroviral naïve HIV-infected adults in Addis Ababa: A cross-sectional study.
Adal M; Howe R; Kassa D; Aseffa A; Petros B
PLoS One; 2018; 13(4):e0195942. PubMed ID: 29672576
[TBL] [Abstract][Full Text] [Related]
8. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
[TBL] [Abstract][Full Text] [Related]
9. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
Anastos K; Lu D; Shi Q; Tien PC; Kaplan RC; Hessol NA; Cole S; Vigen C; Cohen M; Young M; Justman J
J Acquir Immune Defic Syndr; 2007 May; 45(1):34-42. PubMed ID: 17460470
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
Muhammad S; Sani MU; Okeahialam BN
Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
[TBL] [Abstract][Full Text] [Related]
11. Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study.
Jemal M; Shibabaw Molla T; Tiruneh G Medhin M; Chekol Abebe E; Asmamaw Dejenie T
Ann Med; 2023; 55(2):2295435. PubMed ID: 38118463
[TBL] [Abstract][Full Text] [Related]
12. Changes in Lipid Indices in HIV+ Cases on HAART.
Ji S; Xu Y; Han D; Peng X; Lu X; Brockmeyer NH; Wu N
Biomed Res Int; 2019; 2019():2870647. PubMed ID: 30868068
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study.
Tadewos A; Addis Z; Ambachew H; Banerjee S
AIDS Res Ther; 2012 Oct; 9(1):31. PubMed ID: 23095661
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
Padmapriyadarsini C; Ramesh Kumar S; Terrin N; Narendran G; Menon PA; Ramachandran G; Subramanyan S; Venkatesan P; Wanke C; Swaminathan S
Clin Infect Dis; 2011 Feb; 52(4):540-6. PubMed ID: 21252141
[TBL] [Abstract][Full Text] [Related]
15. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
16. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.
Bekolo CE; Nguena MB; Ewane L; Bekoule PS; Kollo B
BMC Public Health; 2014 Mar; 14():236. PubMed ID: 24606888
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
18. Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy.
Mankhatitham W; Luaengniyomkul A; Manosuthi W
J Med Assoc Thai; 2012 Feb; 95(2):163-9. PubMed ID: 22435244
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
Achila OO; Abrhaley F; Kesete Y; Tesfaldet F; Alazar F; Fisshaye L; Gebremeskel L; Mehari R; Andemichael D
PLoS One; 2022; 17(7):e0270838. PubMed ID: 35776747
[TBL] [Abstract][Full Text] [Related]
20. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
